The structural properties of an inherited fibrinogen abnormality designated fibrinogen Paris I were investigated. Dodecyl sulfate gel electrophoresis of unreduced samples revealed no discernible differences in molecular weight from normal; this implied that in fibrinogen Paris I, the normal fibrinogen architecture of six covalently linked chains per molecule is preserved. Examination of dithiothreitol reduced samples before and after treatment with Reptilase or thrombin revealed that the Aalpha- and Bbeta-chains could release the A and B peptides, respectively. A mutant chain (mol wt 52,500, termed gammaParis I) which replaces a large proportion of gamma-chains (mol wt 49,400) was shown, like normal gamma-chains, to lack thrombin- and Reptilase-sensitive sites. The gamma-chains and alpha-chains of Paris I fibrin underwent Factor XIIIa-catalyzed cross-linking slowly; this behavior was not attributable to an intrinsic abnormality of these chains themselves but rather to the inhibitory effect of the mutant gammaParis I chains on this process. Results of DEAE-cellulose gradient elution chromatography of Paris I fibrinogen preparations revealed the presence of small amounts of normal fibrinogen molecules and also indicated that the gammaParis I chains possessed structural overlap with gamma-chains. Unlike gamma-chains however, the gammaParis I chains did not incorporate dansylcadaverine in the prescence of Factor XIIIa, nor, as previously reported, did they undergo cross-linking. The observations indicate that the amine acceptor site found in the COOH-terminal region of the gamma-chain is either not present on the gammaParis I chain or is unavailable for cross-linking. Further support for localization of the abnormality in the COOH-terminal region of the molecule was obtained from the observation that during plasmic hydrolysis of Paris I fibrinogen, at least one unique form of core Fragment D (DParis I) was evolved, whereas Fragment E did not differ from normal.
M W Mosesson, D L Amrani, D Ménaché
Title and authors | Publication | Year |
---|---|---|
Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to γ S378P mutation
MA Keller, J Martinez, TC Baradet, C Nagaswami, IN Chernysh, MK Borowski, S Surrey, JW Weisel |
Blood | 2005 |
Pan Vascular Medicine
P Lanzer, EJ Topol |
2002 | |
The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains
MW Mosesson, KR Siebenlist, DA Meh, JS Wall, JF Hainfeld |
Proceedings of the National Academy of Sciences | 1998 |
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner |
Advances in Protein Chemistry | 1998 |
The location of the carboxy-terminal region of chains in fibrinogen and fibrin D domains
MW Mosesson, KR Siebenlist, DA Meh, JS Wall, JF Hainfeld |
Proceedings of the National Academy of Sciences | 1998 |
γ-Chain Dysfibrinogenemias: Molecular Structure-Function Relationships of Naturally Occurring Mutations in the γ Chain of Human Fibrinogen
HC Côté, S T., KP Pratt |
Blood | 1998 |
A Review of the Hypercoagulable State
CS Eby |
Hematology/Oncology Clinics of North America | 1993 |
A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi
K Yamazumi, K Shimura, S Terukina, N Takahashi, M Matsuda |
Journal of Clinical Investigation | 1989 |
Fibrinogen Sevilla, a congenital dysfibrinogenemia characterized by an abnormal monomer aggregation and a defective plasmin lysis
FJ Fernández, P Noguerol, R Sosa, B Cuesta, JA Páramo, E Rocha |
Clinica Chimica Acta | 1989 |
Formation and regulation of platelet and fibrin hemostatic plug
J Hawiger |
Human Pathology | 1987 |
Two cases of dysfibrinogenemia characterized by abnormal fpb release: fibrinogen madrid I & II
M Borrell, L Vila, J Solá, I Coll, N Gómez, N González, ML Rutllant |
Thrombosis Research | 1987 |
.gamma. and .gamma.' chains of human fibrinogen are produced by alternative mRNA processing
DW Chung, EW Davie |
Biochemistry | 1984 |
Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen
AJ Fornace, DE Cummings, CM Comeau, JA Kant, GR Crabtree |
The Journal of biological chemistry | 1984 |
Congenital Fibrinogen Abnormalities
D Ménaché |
Annals of the New York Academy of Sciences | 1983 |
CHEMICAL MODIFICATION OF FIBRINOGEN AND THE EFFECT ON FIBRIN FORMATION
Y Saito, A Shimizu, A Matsushima, Y Inada |
Annals of the New York Academy of Sciences | 1983 |
An Abnormal Inherited Fibrinogen (Fibrinogen Genova) with Delayed Fibrin Aggregation
HJ Hassan, M Orlando, GP Tonini, P Casalbore, A Sarti, E Boeri, R Giacchino, L Tentori, PG Mori |
Scandinavian Journal of Haematology | 1982 |
Fibrinogen bondy : A new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules
M Jandrot-Perrus, MH Aurousseau, MJ Rabiet, F Josso |
Thrombosis Research | 1982 |
Fibrinogen petoskey: Identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A
DL Higgins, JA Penner, JA Shafer |
Thrombosis Research | 1981 |
Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-A alpha 16 by a histidyl residue. Evidence for thrombin-catalyzed hydrolysis at a histidyl residue
DL Higgins, JA Shafer |
The Journal of biological chemistry | 1981 |
Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma')
C Wolfenstein-Todel, MW Mosesson |
Proceedings of the National Academy of Sciences | 1980 |
Fibrinopeptide release from fibrinogen Paris I
JS Finlayson, LA Reamer, MW Mosesson, D Menache |
Thrombosis Research | 1980 |
Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen
CW Francis, VJ Marder, SE Martin |
The Journal of biological chemistry | 1980 |
Congenital dysfibrinogenemia : Fibrinogen lille
MH Denninger, JS Finlayson, LA Reamer, A Parquet-Gernez, M Goudemand, D Menache |
Thrombosis Research | 1978 |
Human fibrinogen heterogeneities. Preparation and characterization of γ and γ′ chains
NE Stathakis, MW Mosesson, DK Galanakis, D Ménache |
Thrombosis Research | 1978 |
Dysfibrinogen�mie
FR Matthias, WH Krause, S Ganssert, K Mueller, HG Lasch |
Klinische Wochenschrift | 1977 |
Dysfibrinogen�mie: Zugleich ein neuer Fall: Dysfibrinogen�mie Gie�en III
FR Matthias, WH Krause, S Ganssert, K Mueller, HG Lasch |
Klinische Wochenschrift | 1977 |
Hydrolysis of fibrinogen Paris I by plasmin
MW Mosesson, MH Denninger, D Ménaché |
Thrombosis Research | 1976 |
Blut und Blutkrankheiten
L Heilmeyer, K Betke, KG von Boroviczény, D Busch, E Grundmann, H Heimpel, G Hoffmann, W Hunstein, W Keiderling, M Matthes, H Merker, W Müller, P Pfannenstiel |
1968 |